financetom
Business
financetom
/
Business
/
Gap Fiscal Q4 Earnings Rise, Sales Decline; Shares Gain After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gap Fiscal Q4 Earnings Rise, Sales Decline; Shares Gain After Hours
Mar 6, 2025 2:35 PM

05:01 PM EST, 03/06/2025 (MT Newswires) -- Gap (GAP) reported fiscal Q4 net income late Thursday of $0.54 per diluted share, up from $0.49 a year earlier.

Analysts polled by FactSet, on average, expected $0.38.

Net sales for the quarter ended Feb. 1 were $4.15 billion, down from $4.30 billion a year earlier.

Analysts expected $4.07 billion.

For Q1, the apparel retailer is expecting net sales will be flat to slightly higher than its year-ago sales of $3.4 billion. Analysts are looking for $3.44 billion.

For 2025, the company is projecting net sales to grow 1% to 2% over its $15.1 billion in 2024 sales. Analysts expect $15.26 billion.

Gap shares were climbing almost 15% in Thursday's after-hours session.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen Reportedly Signs Licensing Deal With South Korea's Alteogen
Biogen Reportedly Signs Licensing Deal With South Korea's Alteogen
Mar 25, 2026
07:32 AM EDT, 03/25/2026 (MT Newswires) -- Biogen (BIIB) has signed a licensing deal with South Korea's Alteogen for subcutaneous biopharmaceutical formulations based on the ALT-B4 platform, a technology that converts intravenous drugs into subcutaneous injections, news outlets reported Wednesday, citing Alteogen. Under the agreement, Biogen secures exclusive rights to develop and commercialize two biopharmaceutical products using Alteogen's ALT-B4 platform...
Merck to Acquire Terns Pharmaceuticals in $6.7 Billion Deal
Merck to Acquire Terns Pharmaceuticals in $6.7 Billion Deal
Mar 25, 2026
07:32 AM EDT, 03/25/2026 (MT Newswires) -- Merck ( MRK ) has agreed to acquire Terns Pharmaceuticals ( TERN ) for $53 per share in cash, valuing the company at about $6.7 billion, the companies said Wednesday. The purchase price represents a premium of about 31% to Terns' 60-day volume-weighted average price and 42% to its 90-day average stock price,...
SSR Mining Seals Deal to Sell 80% Stake in Copler Mine For US$1.5 Billion Cash
SSR Mining Seals Deal to Sell 80% Stake in Copler Mine For US$1.5 Billion Cash
Mar 25, 2026
07:34 AM EDT, 03/25/2026 (MT Newswires) -- SSR Mining ( SSRGF ) , up 6.4% in pre-market trading, Wednesday said it has signed a definitive agreement to sell its 80% stake in the Copler mine to Cengiz for US$1.5 billion in cash. The transaction, which is subject to Turkish regulatory approval, is expected to close in the third quarter of...
I Bella Perfect Files for Nasdaq IPO to Sell 3.75 Million Shares
I Bella Perfect Files for Nasdaq IPO to Sell 3.75 Million Shares
Mar 25, 2026
07:31 AM EDT, 03/25/2026 (MT Newswires) -- I Bella Perfect (IBP) said Wednesday that it has filed to sell 3.75 million Class A shares in an initial public offering at an expected price range of $4 to $6 per share, according to an amended Form F-1 filed with the US Securities and Exchange Commission. The Malaysian aesthetic medical clinics operator...
Copyright 2023-2026 - www.financetom.com All Rights Reserved